Cancer Test Market worth US$ 14 Billion by 2018

DALLAS, March 26, 2014 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials – Global" to its store that says Cancer testing has tremendous growth opportunities for the next five years.

(Photo: http://photos.prnewswire.com/prnh/20140326/MN91058)

Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018.

This report provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters.

A. Global – Cancer Testing Market and New Cases (Chapter 2)
B. Global – Cancer Testing Market Share & Forecast (Chapter 3)
C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4)
D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5)
E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6)
F. Geographic Region – Number of New Cancer Cases (Chapter 7)
G. Number of New Cancer Cases by Site – Geographic Region Distribution & Clinical Trials (Chapter 8)

Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=157420 .

Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4)

Prostate Specific Antigen (PSA) Test Market & Forecast
Fecal Occult Blood Test Market & Forecast
Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast
Human Papilloma Virus (HPV) Test Market & Forecast
Bladder Test Market & Forecast
Serum Based Cancer Markers Market & Forecast
Pharmacognostic Histology Market & Forecast
Flow Cytometry Market & Forecast
Other Test Market & Forecast

Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5)

Bladder Cancer Test Market & Forecast
Breast Cancer Test Market & Forecast
Cervical Cancer Test Market & Forecast
Colorectal (Colon) Cancer Test Market & Forecast
Ovarian Cancer Test Market & Forecast
Prostate Cancer Test Market & Forecast
Liver Cancer Test Market & Forecast
Flow Cytometry Market & Forecast
Other Organ Specific Cancer Test Market & Forecast

Comprehensive Table of Contents and more for the report "Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials – Global" is available at http://www.rnrmarketresearch.com/cancer-test-market-forecast-companies-cancer-test-platform-pipeline-analysis-and-clinical-trials-global-market-report.html .

Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6)

1. Abbott
2. Radient Pharmaceuticals
3. BD Diagnostics
4. Beckman Coulter, Inc.
5. BioCurex
6. bioMerieux
7. Cepheid
8. CytoCore Inc.
9. DiagnoCure, Inc
10. Gen-Probe, Inc.
11. Genomic Health Inc
12. QIAGEN Marseille (Earlier Ipsogen)
13. Myriad Genetics, Inc
14. Panacea Pharmaceuticals, Inc.
15. Qiagen
16. Siemens Heathcare Diagnostics
17. Roche
18. Ventana Medical Systems
19. Trovagene Inc
20. Vermillion, Inc

Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7)

1. Africa
2. Americas
3. Asia
4. Europe
5. Oceania

Number of New Cancer Cases by Site – Geographic Region Distribution (To 2020) (Chapter 8)

1. Bladder Cancer
2. Brain Cancer
3. Breast Cancer
4. Cervix Cancer
5. Colorectal Cancer
6. Corpus Cancer
7. Hodgkin's Lymphoma
8. Kaposi Sarcoma
9. Kidney Cancer
10. Larynx Cancer
11. Leukaemia
12. Liver Cancer
13. Lung Cancer
14. Melanoma
15. Myeloma
16. Nasopharynx
17. Non-Hodgkin Lymphoma
18. Oesophagus
19. Oral Cavity
20. Other Pharynx
21. Ovary Cancer
22. Pancreas Cancer
23. Prostate Cancer
24. Stomach Cancer
25. Testis Cancer
26. Thyroid Cancer
27. Other Sites

Cancer Site – Clinical Trials (Chapter 8)

1. Bladder Cancer
2. Cervical Cancer
3. Colorectal Cancer
4. Liver Cancer
5. Ovarian Cancer
6. Prostate Cancer

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Browse more reports on Cancer Diagnostics market at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/in-vitro-diagnostics-ivd/cancer-diagnostics .

About Us:

RnR Market Research is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers. Call +1 888 391 5441 with your research requirements or email the details on sales@rnrmarketresearch.com This e-mail address is being protected from spambots. You need JavaScript enabled to view it and we would be happy to help you find the business intelligence that you need.

Media Contact: Priyank Tiwari, RnR Market Research, + 1 888 391 5441, sales@rnrmarketresearch.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE RnR Market Research



RELATED LINKS
http://www.rnrmarketresearch.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.